\
&
Contact us
\
&
Contact us
Starts in 2 months from now
LocationScandic Copenhagen, Denmark
The RTI Summit 2025 brings together key stakeholders from across Europe to shape the future of research and technology infrastructures and launch the new European strategy in the field. The summit aims to provide input and recommendations for the implementation of the strategy and to demonstrate how infrastructures help drive innovation, science, and industry forward.
Target audience: EU and national policymakers, leaders and experts from Research and Technology Infrastructures, industry stakeholders and innovators, research organisations, universities, and funding agencies, EU project consortia and collaborations.
All information related to the conference including the complete programme and practical information is available on the conference website. Registration is required here by 1 September 2025.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
